TY - JOUR
AU - 
TI - Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
JF - The Lancet
DO - 10.1016/s0140-6736(10)60934-8
DA - 2010-08-01
UR - https://www.deepdyve.com/lp/unpaywall/efficacy-of-boceprevir-an-ns3-protease-inhibitor-in-combination-with-vUcSEte6jR
DP - DeepDyve
ER -